Short Term Safety and Effectiveness of Valganciclovir Prophylactic Dosing for Cytomegalovirus in Solid Organ Transplant Recipients Requiring Intermittent Hemodialysis.
BACKGROUND Valganciclovir is the preferred antiviral agent for cytomegalovirus (CMV) prophylaxis in solid organ transplant (SOT) recipients; however, limited data exist to guide optimal dosing in patients requiring intermittent hemodialysis (iHD). This study evaluated the safety and efficacy of our institution's curren...